BIONDVAX PHARMACEUTICALS LTD's ticker is BVXVW and the CUSIP is 09073Q113. A total of 3 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -90.9% | 12,590 | -40.7% | 0.00% | – |
| Q4 2019 | $55,000 | +292.9% | 21,231 | -6.5% | 0.00% | – |
| Q3 2019 | $14,000 | -68.9% | 22,714 | -63.0% | 0.00% | – |
| Q2 2019 | $45,000 | +542.9% | 61,386 | +192.8% | 0.00% | – |
| Q1 2019 | $7,000 | -22.2% | 20,962 | -1.9% | 0.00% | – |
| Q4 2018 | $9,000 | -65.4% | 21,362 | -2.3% | 0.00% | – |
| Q3 2018 | $26,000 | +23.8% | 21,862 | +33.6% | 0.00% | – |
| Q2 2018 | $21,000 | -80.2% | 16,362 | -77.5% | 0.00% | – |
| Q4 2017 | $106,000 | -16.5% | 72,800 | 0.0% | 0.00% | – |
| Q3 2017 | $127,000 | -32.1% | 72,800 | 0.0% | 0.00% | – |
| Q2 2017 | $187,000 | +74.8% | 72,800 | 0.0% | 0.00% | – |
| Q1 2017 | $107,000 | +296.3% | 72,800 | 0.0% | 0.00% | – |
| Q4 2016 | $27,000 | -63.0% | 72,800 | 0.0% | 0.00% | – |
| Q2 2015 | $73,000 | – | 72,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Investment Advisors, LLC | 12,000 | $4,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 72,800 | $27,000 | 0.00% |
| UBS Group AG | 2,001 | $1,000 | 0.00% |